BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
FABP1
,
Response to oxidative stress
,
Influenza
,
Embryo
,
Biofuel
,
Doxorubicin
,
rs2300478
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PD- L1
Summary
General Info
Curated Studies
Most Correlated Studies
Primary and metastatic melanomas - PD-L1 positive or negative
Plasmacytoid dendritic cell stimulated with influenza virus and sorted for PD-L1+ CD80+
CD8+ T cells from OT-1 mice after exposure to PD-L1
Hepatocellular carcinoma HuH-7 cells with shRNA knockdown of L1 retrotransposon protein
Colorectal cancer (HT29 & HCT116) and melanoma PES43 cells treated with Nivolumab, sPD-L1 or both
Explore Curated Studies Results
Literature
Most Relevant Literature
Regulation of post-translational modification of PD-L1 and advances in tumor immunotherapy.
Oral PD-L1 Inhibitors Crowd into the Clinic.
Design, Synthesis, and Biological Evaluation of 2-Hydroxy-4-phenylthiophene-3-carbonitrile as PD-L1 …
Companion Diagnostics: Lessons Learned and the Path Forward From the Programmed Death Ligand-1 Rollo…
What role does PDL1 play in EMT changes in tumors and fibrosis?
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effect of Chemotherapy on PD-L1 in NSCLC
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
GRN-1201 With Pembrolizumab in Subjects With Metastatic PD-L1+ NSCLC
A Real World Study of Anti-PD-1/PD-L1 Antibodies for the Treatment of Advanced Solid Tumors
Combination Therapy With Nivolumab and PD-L1/IDO Peptide Vaccine to Patients With Metastatic Melanom…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ